PHASE II MASTER TIME TABLE : BATCH 2021-2022
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
PHASE II MASTER TIME TABLE : BATCH 2021-2022
Department wise colour coding
Community Medicine
Pathology
Microbiology
Forensic Medicine & Toxicology
Pharmacology
Surgery
Medicine
OBGY
Holiday
AITO TOPICS- 1. Immunology
2. HIV& AIDS
3. Infections & infestations
4. Hematology & Aneamia
5. GIT &Hepatobiliary System
6. Respiratory system
7. CVS1 April to 19July 2022
01/04/2022 Friday MI-L PA-L PH-P- 1.3 CM-P -3.1 3.2
Enumerate and identify
INTRODUCTION TO 1.1 Describe the role of a drug Introduction to water
STAFF AND DEPT pathologist in diagnosis and formulation pollution and
management of disease s and drug purification of water
1.2 Enumerate common delivery
definitions and terms used systems
in Pathology
1.3 Describe the history
and evolution of
Pathology
02/04/2022 Saturday GUDIPADAWA
Date Day 8-9 9-10 2-3 3-4 4-504/04/2022 Monday SUR-L PH-L- 1.1 + 1.9 FM-Lecture -1 PH-P- 1.3 CM-P -3.1 3.2
SU1.1 Describe Basic 1.1 Define and describe Topic: General Enumerate and identify
concepts of homeostasis, the principles of Information drug Water disinfectants &
enumerate the metabolic Pharmacology and FM 1.1 Demonstrate formulation museum visit-Batch A
changes in injury and their Pharmacotherapeutics knowledge of basics of s and drug
mediators. 1.9 Describe Forensic Medicine like delivery
SU1.2Describe the factors nomenclature of drugs definitions of Forensic systems
that affect the metabolic i.e. generic, medicine, Clinical Forensic
response to injury. branded Medicine, Forensic
SU1.3Describe basic drugs Pathology, State Medicine,
concepts of perioperative Legal Medicine and
care. Medical Jurisprudence
FM1.3 Describe legal
procedures including
Criminal Procedure Code,
Indian Penal Code, Indian
Evidence Act, Civil and
Criminal Cases, Inquest
(Police Inquest and
Magistrate’s Inquest),
Cognizable and Non-
cognizable offences
FM1.4 Describe Courts in
India and their powers:
Supreme Court, High Court,
Sessions court, Magistrate’s
Court, Labour Court, Family
Court, Executive Magistrate
Court and Juvenile Justice
Board
05/04/2022 Tuesday CM-L -3.2 Introduction to PH-L - 1.11 MI-P PA-P SGD FM- Lecture -2
environmental sanitation and Describe Topic: General Information
safe & wholesome water, Various routes of drug HISTORY OF 1.2 Enumerate common FM1.5 Describe Court
administration, eg., oral, MICROBIOLOGY definitions and terms procedures including issue of
SC, used in Pathology Summons, conduct money,
IV, IM, SL 1.3 Describe the history types of witnesses, recording
of evidence oath, affirmation,
and evolution of examination in chief, cross
Pathology examination, re-examination
BATCH A and court questions, recording
of evidence & conduct of
doctor in witness box
FM1.6 Describe Offenses in
Court including Perjury;
Court strictures vis-a- vis
Medical Officer
FM1.7 Describe Dying
Declaration & Dying
Deposition06/04/2022 Wednesday MED-L PA-L PH- P -4.1 PA-P SGD MI-P 1.2 A
Administered drugs through SGD
IM9.1 Define, describe and 2.1 Demonstrate knowledge various routes in simulated 1.2 Enumerate common
classify anemia based on red of the causes, mechanisms, environment using manikins definitions and terms Perform and identify the
blood cell size and types and effects of cell (Drug Administration by used in Pathology different causative agents of
reticulocyte count injury and their clinical routes in mannequins) 1.3 Describe the history Infectious diseases by Gram
significance Stain, ZN stain and stool
2.2 Describe the etiology of
and evolution of routine microscopy–
cell injury. Distinguish Pathology
between reversible- BATCH B Microscopy & importance
irreversible injury: of staining
mechanisms; morphology
of cell injury
07/04/2021 Thursday OBG-L PA-L PH- P -4.1 PA-P SGD MI-P 1.2 A
O-G 2.1/AN48.8,AN49.2 Administered drugs through SGD
Anatomy of female 2.3 Intracellular various routes in simulated 2.1 Demonstrate knowledge
reproductive Tract accumulation of fats, environment using manikins of the causes, mechanisms, Perform and identify the
proteins, carbohydrates, (Drug Administration by types and effects of cell different causative agents of
pigments routes in mannequins) injury and their clinical Infectious diseases by Gram
significance Stain, ZN stain and stool
2.2 Describe the etiology of routine microscopy–
cell injury. Distinguish
between reversible- Microscopy & importance
irreversible injury: of staining
mechanisms; morphology
of cell injury
BATCH A
08/04/2022 Friday MI-L PA-L PH-P 1.3 CM-P -3.1 3.2
1.1 A Enumerate and identify
Describe the different 2.4 Describe and discuss drug Water disinfectants &
causative agents of Cell death- types, formulation museum visit-Batch B
Infectious diseases+A208, mechanisms, necrosis, s and drug
the methods used in their apoptosis (basic as delivery
detection, and discuss the contrasted with necrosis), systems
role of microbes in health autolysis
and disease-
Bacterial Inf09/04/2022 Saturday 10:00 AM-1:00 PM MI-L PH-L - 1.4 FM- Lecture - 2 PA-P SGD
1.1 A Describe Topic: General
Orientation of the Phase II Describe the different absorption, Information 2.1 Demonstrate knowledge
curriculum causative agents of distribution, FM1.5 Describe Court of the causes, mechanisms,
Infectious diseases+A208, metabolism procedures including issue types and effects of cell injury
the methods used in their &excretion of Summons, conduct and their clinical significance
detection, and discuss the of drugs money, types of witnesses, 2.2 Describe the etiology of
role of microbes in health recording of evidence oath, cell injury. Distinguish
and disease- affirmation, examination in between reversible-
chief, cross examination, re- irreversible injury:
Viral Inf examination and court mechanisms; morphology of
questions, recording of cell injury
evidence & conduct of BATCH B
doctor in witness box
FM1.6 Describe Offenses
in Court including Perjury;
Court strictures vis-a- vis
Medical Officer
FM1.7 Describe Dying
Declaration & Dying
Deposition
Date Day 8-9 9-10 2-3 3-4 4-5
11/04/2021 Monday SUR-L PH-L - 1.4 FM-SDL -1 PH-P-4.1 CM-P -3.2
SU5.1 Describe normal Describe FM1.2 Describe history of Administered drugs through
wound healing and factors absorption, Forensic Medicine various routes in simulated Water-Problem
affecting healing. distribution, environment using manikins solving, Interpretation
SU5.3 Differentiate the metabolism (Drug Administration by of water analysis
various types of wounds, &excretion routes in mannequins)
plan and of drugs report Batch A
observemanagement of
12/04/2021 Tuesday wounds.
CM -L PH-L- 1.4 MI-P PA-P SGD FM- SGD -1
SU5.4Discuss medico
SDL -3.2Sanitary legalof
sources Describe Seminar - 1.2 B 23.1 (Part I) Skills in Forensic Medicine
aspects of wounds
water,pollution,diseases,wat absorption, Perform and identify the Describe abnormal urinary & Toxicology
er conservation & rainwater distribution, different causative agents of findings in disease states FM14.20 To record and
harvesting-Seminar metabolism Infectious diseases by Gram and identify and describe certify dying declaration in a
&excretion Stain, ZN stain and stool common urinary simulated/ supervised
of drugs routine microscopy– abnormalities in a clinical environment
specimen
Gram Stain BATCH A13/04/2022 Wednesday MED-L PA-L PH- P - SGD-1.4 PA-P SGD MI-P
IM9.2 Describe 23.1 (Part I) 1.2 B
Describe and discuss the 2.5 Describe and discuss absorption, Describe abnormal urinary SGD
morphological pathologic calcifications, distribution, findings in disease states Perform and identify the
characteristics, aetiology and gangrene metabolism and identify and describe different causative agents of
prevalence of each of the &excretion common urinary Infectious diseases by Gram
causes of anemia of drugs abnormalities in a clinical Stain, ZN stain and stool
specimen routine microscopy–
BATCH B
Gram Stain
14/04/2022 Thursday
AMBEDKAR JAYANTHI
15/04/2022 Friday
GOOD FRIDAY
16/04/2022 Saturday 10:00 AM-1:00 PM MI-L PH-L- 1.4 FM- SGD -1 PA-P SGD
Pandemic Module 2.1 1.1 C Describe the different Describe Skills in Forensic 2.3 Intracellular accumulation
Microbiology causative agents of absorption, Medicine & Toxicology of fats, proteins,
1.Interactive Discussion-1 hr Infectious diseases+A208, distribution, FM14.20 To record and carbohydrates, pigments
2. Small grp case discussion the methods used in their metabolism certify dying declaration in 2.4 Describe and discuss Cell
f/b pleneary-1.5 hrs detection, and discuss the &excretion a simulated/ supervised death- types, mechanisms,
role of microbes in health of drugs environment necrosis, apoptosis (basic as
and disease- contrasted with necrosis),
autolysis
Mycology Inf 2.5 Describe and discuss
pathologic calcifications,
gangrene
BATCH B
Date Day 8-9 9-10 2-3 3-4 4-518/04/2022 Monday SUR-L PH-L - 1.5 FM-Lecture – 3Topic: PH-P-4.1 CM-P3.2
SU 2.1 Describe Describe General Information Administered drugs
Pathophysiology of shock, general FM1.8 Describe the latest through various routes in Visit to water filtration
types of shock & principles principles decisions/notifications/resol simulated environment plantBatch A
of resuscitation including of utions/ circulars/standing using manikins (Drug
fluid replacement and mechanism orders related to medico- Administration by routes in
monitoring. of drug legal practice issued by mannequins)
SU2.2 Describe the clinical action Courts/Government
features of shock and its authorities etc.
appropriate treatment F.M1.9 Describe the
importance of
documentation in medical
practice in regard to
medicolegal examinations,
Medical Certificates and
19/04/2022 Tuesday CM-L -3.2 PH-L- 1.5 MI-P
medicolegal reports PA-P SGD FM- SGD -2
Water purification processes Describe Seminar-1.2 C Perform and 2.3 Intracellular Topic: General Information
& water quality standards general identify the different accumulation of fats, FM 2.29 Demonstrate respect
principles causative agents of proteins, carbohydrates, to the directions of courts,
of Infectious diseases by Gram pigments while appearing as witness for
mechanism Stain, ZN stain and stool 2.4 Describe and discuss recording of evidence under
of drug routine microscopy– Cell death- types, oath or affirmation,
action mechanisms, necrosis, examination in chief, cross
Z-N Stain apoptosis (basic as examination, re-examination
contrasted with necrosis), and court questions, recording
autolysis of evidence
2.5 Describe and discuss Skills in Forensic Medicine
pathologic calcifications, & Toxicology FM14.22 To
gangrene give expert medical/ medico-
BATCH A legal evidence in Court of law
20/04/2022 Wednesday MED-L PA-L PH-T- 1.4 PA-P SGD MI- P
Describe 23.1 (Part II) SGD1.2 CPerform and
IM9.7 2.6 Describe and discuss absorption, Describe abnormal urinary identify the different causative
Describe and discuss the cellular adaptations: distribution, findings in disease states agents of Infectious diseases
meaning and utility of atrophy, hypertrophy, metabolism and identify and describe by Gram Stain, ZN stain and
various components of the hyperplasia, metaplasia, &excretion common urinary stool routine microscopy–
hemogram dysplasia of drugs abnormalities in a clinical
specimen Z-N Stain
BATCH B21/04/2022 Thursday OBG-L PA-L PH-P-1.12 PA-P SGD MI-P
OG 3.1. PE 14.3 23.1 (Part II) 1.2 B
2.7 Describe and discuss Calculate the dosage of Describe abnormal urinary SGD
Physiology of the mechanisms of cellular findings in disease states Perform and identify the
drugs using appropriate
menstruation aging and apoptosis formulae for an individual and identify and describe different causative agents of
patient, including common urinary Infectious diseases by Gram
abnormalities in a clinical Stain, ZN stain and stool
children, elderly and
specimen routine microscopy–
patient with renal BATCH A Gram Stain
dysfunction SGD1.2 CPerform and
identify the different causative
agents of Infectious diseases
by Gram Stain, ZN stain and
stool routine microscopy–
Z-N Stain
22/04/2022 Friday MI-L PA-L PH-P-4.1 CM-P- 3.2
1.1 D Describe the different Administered drugs
causative agents of 3.1 Describe the through various routes in Water-Problem
Infectious diseases+A208, pathogenesis and pathology simulated environment solving, Interpretation
the methods used in their of amyloidosis using manikins (Drug of water analysis
detection, and discuss the 3.2 Identify and describe Administration by routes in
role of microbes in health amyloidosis in a pathology mannequins) report Batch B
and disease- specimen
CM-P 3.2
Parasitic Inf
Visit to water filtration
plantBatch
23/04/2022 Saturday 10:00 AM-1:00 PM MI-L PH-L - 1.6 FM-SGD - 2 PA-P SGD
Pandemic Module 2.1 8.9 Discuss the appropriate Describe principles Topic: General 2.6 Describe and discuss
Microbiology method of collection of of Pharmacovigilance& Information cellular adaptations: atrophy,
samples in the performance ADR reporting FM 2.29 Demonstrate hypertrophy, hyperplasia,
3. Visit to isolation ward- 1 of laboratory tests in the systems respect to the directions of metaplasia, dysplasia
hr detection of microbial courts, while appearing as 2.7 Describe and discuss the
4. Debriefing & feedback- agents causing infectious witness for recording of mechanisms of cellular aging
30 min diseases evidence under oath or and apoptosis
affirmation, examination in 2.8 Identify and describe
Interactive session on PPE Sample collection chief, cross examination, various forms of cell injuries,
usage protocol re-examination and court their manifestations and
questions, recording of consequences in gross and
evidence microscopic specimens
Skills in Forensic BATCH B
Medicine & Toxicology
FM14.22 To give expert
medical/ medico-legal
evidence in Court of law
Date Day 8-9 9-10 2-3 3-4 4-525/04/2022 Monday SUR-L PH-L- 1.7 + 1.8 FM-Lecture - 4 PH-P -3.4 CM-P 3.2
SU4.1 Elicit document and 1.7 Define, identify and Clinical Forensic Medicine Adverse drug reaction-
present history in a case of describe the management IDENTIFICATION identification and
Visit to District Public
Burns and perform of adverse drug FM 3.1 Define and describe reporting Health Laboratory
physical examination. reactions (ADR) Corpus Delicti, Batch A
Describe Pathophysiology of 1.8 Identify and establishment of identity of
Burns. describe the living persons including
SU4.2 Describe Clinical management of drug race, Sex, religion,
features, Diagnose type and interactions complexion, stature, age
extent of burns andplan determination using
appropriate treatment. morphology, teeth-eruption,
SU4.3 Discuss the decay, bite marks, bones-
Medicolegal aspects in burn ossification centres, medico-
injuries. legal aspects of age-Part 1
26/04/2022 Tuesday CM-SDL -3.1 PH-L 1.64 MI-P PA-P SGD FM- SGD - 3
Air Describe overview of drug Seminar-1.2 D Perform and 2.6 Describe and discuss Clinical Forensic Medicine
quality,airpollution,healthha development, Phases of identify the different cellular adaptations: IDENTIFICATION
zards,indicators, clinical trials and Good causative agents of atrophy, hypertrophy, FM 3.1 age determination
Prevention & control Clinical Practice Infectious diseases by Gram hyperplasia, metaplasia, using morphology, teeth-
Stain, ZN stain and stool dysplasia eruption, bonesossification
routine microscopy– 2.7 Describe and discuss the centres, medico-legal aspect
mechanisms of cellular of age
Stool Examination aging and apoptosis
27/04/2022 Wednesday MED-L PA-L PH- P 3.4 2.8 Identify
PA-P SGD and describe MI-P
Adverse drug reaction- various forms of cell SGD
IM9.8 4.1 Define and describe the injuries, theirthe
3.1 Describe 1.2 D Perform and identify
identification and
Describe and discuss the general features of acute manifestations
pathogenesis and andpathology the different causative agents
reporting consequences
various tests for iron and chronic inflammation of amyloidosis gross and
in of Infectious diseases by
deficiency including stimuli, vascular microscopic
3.2 specimens
Identify and describe Gram Stain, ZN stain and
and cellular events BATCH
amyloidosisA in a pathology stool routine microscopy–
specimen
Stool Examination
BATCH B
28/04/2022 Thursday OBG-L PA-L PH-P 3.4 PA-P SGD MI-P
OG 3.1 AN 77.3,77.4 Adverse drug reaction- SGD
Physiology of 4.2 Enumerate and describe identification and 3.1 Describe the 1.2 D Perform and identify
the mediators of acute reporting pathogenesis and pathology the different causative agents
gametogenesis, inflammation of amyloidosis of Infectious diseases by
Ovulation, conception, 3.2 Identify and describe Gram Stain, ZN stain and
implantation , & amyloidosis in a pathology stool routine microscopy–
reproductive specimen
Stool Examination
endocrinology BATCH A29/04/2021 Friday MI-L PA-L PH-P 3.4 CM-P3.2
1.6 Describe the Adverse drug reaction-
mechanisms of drug 4.3 (PART - I) identification and
Visit to District
resistance, and the methods Define and describe chronic reporting Public Health
of antimicrobial inflammation including Laboratory
susceptibility testing and causes, types, non-specific
monitoring of antimicrobial and granulomatous; and Batch B
therapy- enumerate examples of each
Bacterial Genetics &
Mechanisms of drug
30/04/2022 Saturday 10:00 AM-1:00 PM resistance-I
MI-L PH-L - 1.2 FM- SGD - 3 PA-P SGD
FORMATIVE 1.6 Describe the Describe the basis of Clinical Forensic
ASSESSMENT mechanisms of drug Evidence based Medicine 4.1 Define and describe the
PATHOLOGY& resistance, and the methods Medicine and IDENTIFICATION general features of acute and
FEEDBAK of antimicrobial Therapeutic drug FM 3.1 age determination chronic inflammation
susceptibility testing and monitoring using morphology, teeth- including stimuli, vascular
monitoring of antimicrobial eruption, bones ossification and cellular events
therapy- centres, medico-legal aspect 4.2 Enumerate and describe
of age the mediators of acute
Bacterial Genetics & inflammation
Mechanisms of drug
resistance-II BATCH B
Date Day 8-9 9-10 2-3 3-4 4-5
02/05/2022 Monday SUR - L PH-L -1.13 FM-Lecture -5 PH-P -2.1 CM-P3.2
SU14.1 Describe Aseptic Describe mechanism of Clinical Forensic Medicine Demonstrate understanding
techniques, sterilization and action, types, doses, side IDENTIFICATION of the use of various dosage Exercise on
disinfection. effects, indications and FM 3.1 Define and describe forms interpretation of water
SU14.2 Describe Surgical contraindications of Corpus Delicti, Analysis report
approaches, incisions and adrenergic and anti- establishment of identity of
the use of appropriate adrenergic drugs living persons including Batch A
instruments in Surgery in race, Sex, religion,
general. complexion, stature, age
SU14.3 Describe the determination using
materials and methods used morphology, teeth-eruption,
for surgical wound decay, bite marks, bones-
closure and anastomosis ossification centres, medico-
(sutures, knots and needles) legal aspects of age-Part 2
03/05/2022 Tuesday RAMZAN4/05/2022 Wednesday MED-L PA-L PH- SGD-1.5 PA-P SGD MI-P
Describe
IM9.11 4.3 (PART - II) general 4.3 Define and describe SGD-
Describe the indications and Define and describe chronic principles chronic inflammation
interpret the results of a inflammation including of including causes, types, Sterilisation & Disinfection
bone marrow aspirations and causes, types, non-specific mechanism non-specific and Techniques
biopsy and granulomatous; and of drug granulomatous; and
enumerate examples of action enumerate examples of each
each 4.4 Identify and describe
acute and chronic
inflammation in gross and
microscopic specimens
BATCH B
05/05/2022 Thursday OBG-L PA-L PH-T -1.5 PA-P SGD MI-P
OG 4.1 AN 80.3 80.5, Describe
80.6 13.1 Describe general 4.1 Define and describe the SGD-
Early development of hematopoiesis and principles general features of acute
embryo and fetus, extramedullary of and chronic inflammation Sterilisation & Disinfection
development of Placenta, hematopoiesis mechanism including stimuli, vascular Techniques
amniotic fluid, cord 13.2 Describe the role of of drug and cellular events
anticoagulants in action 4.2 Enumerate and describe
hematology the mediators of acute
inflammation
BATCH A
06/05/2022 Friday MI-L PA-L PH- P - 2.1 CM-P3.2
8.8 Describe the methods Demonstrate understanding
used and significance of 13.3 Define and classify of the use of various dosage Exercise on
assessing the microbial anemia forms interpretation of water
contamination of food, 13.4 Enumerate and Analysis report
water and air describe the investigation of
anemia Batch B
Food,water& air
Testing07/05/2022 Saturday 10:00 AM-1:00 PM MI-L PH-L - 1.13 FM-P SGD - 4 PA-P SGD
FORMATIVE 3.1A Enumerate the Describe mechanism of IDENTIFICATION
ASSESSMENT microbial agents causing action, types, doses, side FM 3.2 Dactylography, foot 13.1 Describe
MICROBIOLOGY& diarrhoea and dysentery. effects, indications and prints, scars, tattoos, hematopoiesis and
FEEDBACK Describe the epidemiology, contraindications of poroscopy and extramedullary
morphology, pathogenesis, adrenergic and anti- superimposition hematopoiesis
clinical features and adrenergic drugs 13.2 Describe the role of
diagnostic modalities of anticoagulants in
these agents- hematology
E.coli (GI Infection) BATCH B
Date Day 8-9 9-10 2-3 3-4 4-5
09/05/2022 Monday SUR-L PH-L 1.13 FM-Lecture -6 PH-P 2.1 CM-P3.4
SU11.1 Describe principles Describe mechanism of IDENTIFICATION Demonstrate understanding
of Preoperative assessment. action, types, doses, side FM 3.2 Describe and of the use of various dosage Visit to sewage
SU11.2 Enumerate the effects, indications and discuss identification of forms purification plant
principles of general, contraindications of criminals, unknown persons, Batch A
regional, and local adrenergic and anti- dead bodies from the
Anaesthesia. adrenergic drugs remains-hairs, fibres, teeth,
SU 10.1 Describe the anthropometry,
principles of perioperative dactylography, foot prints,
management of common scars, tattoos, poroscopy and
surgical procedures superimposition
10/05/2022 Tuesday CM -L PH-L 1.14 MI-P PA-P SGD FM-P SGD - 4
CM-SDL 13.1 13.2 13.3 Describe mechanism of 1.6 Describe the IDENTIFICATION
13.4 action, types, doses, side mechanisms of drug 4.3 Define and describe FM 3.2 Dactylography, foot
Disaster Management: effects, indications and resistance, and the methods chronic inflammation prints, scars, tattoos,
concepts, cycle, manmade contraindications of of antimicrobial including causes, types, poroscopy and
disasters, National disaster cholinergic and susceptibility testing and non-specific and superimposition
management Authority anticholinergic drugs monitoring of antimicrobial granulomatous; and
therapy- enumerate examples of each
4.4 Identify and describe
AST (With DEMO) acute and chronic
inflammation in gross and
microscopic specimens
BATCH A11/05/2022 Wednesday MED-L PA-L PH-T- 1.13 PA-P SGD MI-P
Describe mechanism of SGD/DOAP
IM9.12 14.1 Describe iron action, types, doses, side 13.3 Define and classify 1.2 B Perform and identify
Describe, develop a metabolism effects, indications and anemia the different causative agents
diagnostic plan to determine 14.2 Describe the etiology, contraindications of of Infectious diseases by
the aetiology of anemia investigations and adrenergic and anti- BATCH B Gram Stain, ZN stain and
differential diagnosis of adrenergic drugs stool routine microscopy –
microcytic hypochromic
anemia Gram Stain-
14.3 Identify and describe HANDS ON -REVISION
the peripheral smear in
microcytic anemia
12/05/2022 Thursday OBG-L PA-L PH- SGD-1.14 PA-P SGD MI-P
OG 2.1 AN 52. 8, 79.4 Describe mechanism of SGD/DOAP
Embryology and 15.1 Describe the action, types, doses, side 13.1 Describe 1.2 B Perform and identify
developmental defects of metabolism of Vitamin B12 effects, indications and hematopoiesis and the different causative agents
female genital tract and the etiology and contraindications of extramedullary of Infectious diseases by
pathogenesis of B12 cholinergic and hematopoiesis Gram Stain, ZN stain and
deficiency anticholinergic drugs 13.2 Describe the role of stool routine microscopy –
15.2 Describe laboratory anticoagulants in
investigations of hematology Gram Stain-
macrocytic anemia HANDS ON -REVISION
15.3 Identify and describe BATCH A
the peripheral blood picture
of macrocytic anemia
15.4 Enumerate the
differences and describe the
etiology and distinguishing
features of megaloblastic
and non-megaloblastic
macrocytic anemia
13/05/2022 Friday MI-L PA-L PH-P 2.1 CM-P3.4
3.1B, 3.3 Demonstrate understanding
Describe the enteric fever 16.1 Define and classify of the use of various dosage Visit to sewage
pathogens and discuss the hemolytic anemia forms purification plant
evolution of the clinical 16.2 Describe the Batch B
course and the laboratory pathogenesis and clinical
diagnosis of the diseases features and hematologic
caused by them- indices of hemolytic anemia
16.3 Describe the
Salmonella pathogenesis, features,
hematologic indices and
peripheral blood picture of
sickle cell anemia and
thalassemia14/05/2022 Saturday 10:00 AM-1:00 PM MI-L PH-1.14 FM-P SGD - 5 PA-P SGD
FORMATIVE 3.1C SDL-1 Forensic Pathology
ASSESSMENT Enumerate the microbial Describe mechanism of FM2.11 Describe and 13.4 Enumerate and describe
PHARMACOLOGY& agents causing diarrhea and action, types, doses, side discuss autopsy procedures the investigation of anemia
FEEDBACK dysentery. Describe the effects, indications and including postmortem
epidemiology, morphology, contraindications of examination, different types BATCH B
pathogenesis, clinical cholinergic and of autopsies, aims and
features and diagnostic anticholinergic drugs objectives of post-mortem
modalities of these agents- examination
FM2.12 Describe the legal
Vibrio,Campylobacter requirements to conduct
post-mortem examination
and procedures to conduct
medico-legal post-mortem
examination
FM2.13 Describe and
discuss obscure autopsy
FM2.14 Describe and
discuss examination of
clothing, preservation of
viscera on post-mortem
examination for chemical
analysis and other medico-
legal purposes, post-mortem
artefacts
Date Day 8-9 9-10 2-3 3-4 4-5
16/05/2022 Monday BUDDHA PURNIMA17/05/2022 Tuesday CM-L -3.5 PH-L-1.16 MI-P PA-P SGD FM-P SGD - 5
Standards of housing& Describe mechanism/ s of 8.10 Demonstrate the Forensic Pathology
Ventilation and the effect of action, types, doses, side appropriate method of 13.3 Define and classify FM2.11 Describe and
housing on health effects, indications and collection of samples in the anemia discuss autopsy procedures
contraindications of the performance of laboratory including postmortem
tests in the detection of BATCH A examination, different types
drugs which act by
microbial agents causing of autopsies, aims and
modulating autacoids, Infectious diseases- objectives of post-mortem
including: anti- examination
histaminic, 5-HT Culture Media FM2.12 Describe the legal
modulating drugs, requirements to conduct
NSAIDs, drugsfor gout, post-mortem examination
anti rheumaticdrugs , and procedures to conduct
drugs for migraine medico-legal post-mortem
examination
FM2.13 Describe and
discuss obscure autopsy
FM2.14 Describe and
discuss examination of
clothing, preservation of
viscera on post-mortem
examination for chemical
analysis and other medico-
legal purposes, post-mortem
artefacts
18/05/2022 Wednesday MED-L PA-L PH- SGD - 1.13 PA-P MI-P-
Describe mechanism of SGD SGD
IM9.14 16.4 Describe the etiology action, types, doses, side 8.10,8.11,8.12,8.14-
Describe the national pathogenesis, hematologic effects, indications and REVISION PRACTICAL Demonstrate the appropriate
programs for anemia indices and peripheral contraindications of BATCH B method of collection of
prevention blood picture of Acquired adrenergic and anti- samples in the performance
hemolytic anemia adrenergic drugs of laboratory tests in the
16.5 Describe the detection of microbial agents
peripheral blood picture in causing Infectious diseases-
different hemolytic
anaemias Culture Media
16.6 Prepare a peripheral
19/05/2022 Thursday OBG-L blood
PA-L smear and identify PH-T -1.14 PA-P SGD MI-P-
OG 6.1 FM3.19, PY 9.10 hemolytic anaemia from it Describe mechanism of SGD
16.7 Describe
5.1 Define andthe correctthe
describe action, types, doses, side 13.4 Enumerate and describe 8.10,8.11,8.12,8.14-
Diagnosis of pregnancy
technique
process of repair and a
to perform effects, indications and the investigation of anemia Demonstrate the appropriate
cross match including
regeneration contraindications of method of collection of
wound healing and its types cholinergic and BATCH A samples in the performance
anticholinergic drugs of laboratory tests in the
detection of microbial agents
causing Infectious diseases-
Culture Media20/05/2022 Friday MI-L PA-L PH-P. 2.1 Demonstrate CM-P3.6
3.1D Enumerate the understanding the uses of
microbial agents causing 6.1 Define and describe various dosage forms Visit to office of
diarrhea and dysentery. edema, its types, District Vector borne
Describe the epidemiology, pathogenesis and clinical disease control
morphology, pathogenesis, correlations
clinical features and 6.2 Define and describe programme
diagnostic modalities of hyperemia, congestion, Batch B
these agents- hemorrhage
21/05/2022 Saturday 10:00 AM-1:00 PM Shigella
MI-L PH-L-1.16 FM-P SGD - 6 PA-P SGD
3.1 E Enumerate the Describe mechanism/ s of Forensic Pathology
Pandemic Module 2.2 microbial agents causing action, types, doses, side FM 2.15 Describe special 13.5 Perform, Identify and
Microbiology diarrhea and dysentery. effects, indications and protocols for conduction of describe the peripheral blood
Describe the epidemiology, contraindications of the medico-legal autopsies in picture in anemia
1. Exploratory & morphology, pathogenesis, cases of death in custody or
drugs which act by
interactive theory clinical features and following violation of human BATCH B
session-1hr diagnostic modalities of modulating autacoids, rights as per National Human
2. Self study& small these agents- including: anti-histaminic, Rights Commission
grp assignment- 5-HT Guidelines
2hrs E.histolytica, Giardia modulating drugs, NSAIDs, FM2.16 Describe and
drugsfor gout, anti discuss examination of
rheumaticdrugs , drugs for mutilated bodies or
migraine fragments, charred bones and
bundle of bones.
FM2.17 Describe and
discuss exhumation.
FM2.18 Crime Scene
Investigation:- Describe and
discuss the objectives of
crime scene visit, the duties
& responsibilities of doctors
on crime scene and the
reconstruction of sequence of
events after crime scene
investigation
Date Day 8-9 9-10 2-3 3-4 4-523/05/2022 Monday SUR-L PH-L-1.16 FM-Lecture - 7 PH-P -4.2 CM-P3.6
SU11.4 Enumerate the Describe mechanism/ s of Forensic Pathology Demonstrate the effects of
indications and principles of action, types, doses, side FM2.1 Define, describe and drugs on blood pressure Visit to office of
day care GeneralSurgery. effects, indications and discuss death and its types using computer aided District Vector borne
SU11.5 Describe principles contraindications of the including learning (Drugs on BP disease control
of providing post-operative somatic/clinical/cellular, (CAL)
pain relief and management
drugs which act by
molecular and brain-death, programme
of chronic pain. modulating autacoids, Cortical Death and Batch A
SU11.6 Describe Principles including: anti- Brainstem Death
of safe General Surgery histaminic, 5-HT FM2.2 Describe and discuss
modulating drugs, natural and unnatural deaths
NSAIDs, drugsfor gout, FM2.3 Describe and discuss
anti rheumaticdrugs , issues related to sudden
drugs for migraine natural deaths
24/05/2022 Tuesday CM-SDL --3.7Poster PH-L-1.16 MI-P PA-P SGD FM-P SGD - 6
presentation on various Describe mechanism/ s of 3.6 Describe the etio- Forensic Pathology
types of pollution & action, types, doses, side pathogenesis of Acid peptic 13.5 Perform, Identify and FM 2.15 Describe special
hazards(air,noise,water,radia effects, indications and disease (APD) and the describe the peripheral blood protocols for conduction of
tion) contraindications of the clinical course. Discuss the picture in anemia medico-legal autopsies in
diagnosis and management cases of death in custody or
drugs which act by
of the causative agent of BATCH A following violation of
modulating autacoids, human rights as per National
including: anti- APD Human Rights Commission
histaminic, 5-HT Guidelines
modulating drugs, FM2.16 Describe and
NSAIDs, drugsfor gout, discuss examination of
anti rheumaticdrugs , mutilated bodies or
drugs for migraine fragments, charred bones
and bundle of bones.
FM2.17 Describe and
discuss exhumation.
FM2.18 Crime Scene
Investigation:- Describe and
discuss the objectives of
crime scene visit, the duties
& responsibilities of doctors
on crime scene and the
reconstruction of sequence
of events after crime scene
investigation25/05/2022 Wednesday MED-L PA-L PH-T -1.16 PA-P SGD MI-P-
Describe mechanism/ s of SGD
IM9.17 6.3 Define and describe action, types, doses, side 14.1 Describe iron 8.10,8.11,8.12,8.14-
Describe the indications for shock, its pathogenesis and effects, indications and metabolism Demonstrate the appropriate
blood transfusion and the its stages contraindications of the method of collection of
appropriate use of blood BATCH B samples in the performance
drugs which act by
components of laboratory tests in the
modulating autacoids, detection of microbial agents
including: anti-histaminic, causing Infectious diseases-
5-HT
modulating drugs, NSAIDs, Culture Methods
drugsfor gout, anti
26/05/2022 Thursday OBG-L PA-L PH-SGD-1.16
rheumaticdrugs , drugs for PA-P SGD MI-P-
OG 7.1 PY 9.8 Describe mechanism/ s of
migraine SGD
Physiological changes in 6.4 Define and describe action, types, doses, side 14.1 Describe iron 8.10,8.11,8.12,8.14-
pregnancy normal haemostasis and the effects, indications and metabolism Demonstrate the appropriate
etiopathogenesis and contraindications of the method of collection of
consequences of BATCH A samples in the performance
drugs which act by
thrombosis of laboratory tests in the
6.5 Define and describe modulating autacoids, detection of microbial agents
embolism and its causes including: anti-histaminic, causing Infectious diseases-
and common types 5-HT
modulating drugs, NSAIDs, Culture Methods
drugsfor gout, anti
rheumaticdrugs , drugs for
migraine
27/05/2022 Friday MI-L PA-L PH-P -4.2 CM P
3.1 F1- Enumerate the Demonstrate the effects of
microbial agents causing 6.6 Define and describe drugs on blood pressure 3.7Demonstration:Id
diarrhea and dysentery. Ischaemia/infarction its using computer aided entifying
Describe the epidemiology, types, etiology, morphologic learning (Drugs on BP characteristics of
morphology, pathogenesis, changes and clinical effects (CAL)
clinical features and vectors of public
diagnostic modalities of health importance
these agents- Batch B
Cestodes-I28/05/2022 Saturday 10:00 AM-1:00 PM MI-L PH-L -1.15 FM-P SGD - 7 PA-P SGD
PH-L-1.26 3.1 F2- Enumerate the PY-3.5-AS-4.1 Forensic Pathology
IM-1.24 microbial agents causing Describe mechanism / s of FM1.10 Select appropriate 14.2 Describe the etiology,
Describe mechanisms of diarrhea and dysentery. action, types, doses, side cause of death in a particular investigations and
action, types, doses, side Describe the epidemiology, effects, indications and scenario by referring ICD 10 differential diagnosis of
effects, indications and morphology, pathogenesis, contra-indications of code microcytic hypochromic
contraindications of the clinical features and skeletal muscle relaxants FM1.11Write a correct cause anemia
drugs modulating the RAS diagnostic modalities of of death certificate as per 14.3 Identify and describe
renin- angiotensin and these agents- ICD 10 document the peripheral smear in
aldosterone system microcytic anemia
Cestodes-II
BATCH B
Date Day 8-9 9-10 2-3 3-4 4-5
30/05/2022 Monday SUR-L PH-L-1.24 FM-Lecture -8 PH-P -4.2 CM P
SU12.2 Describe and Describe the mechanism/s Forensic Pathology Demonstrate the effects of
discuss the methods of of action, types, doses, FM2.5 Discuss moment of drugs on blood pressure 3.7Demonstration:Id
estimation and replacement side effects, indications death, modes of death - using computer aided entifying
ofthe fluid and electrolyte and contraindications of coma, asphyxia and syncope learning (Drugs on BP characteristics of
requirements in the surgical the drugs affecting renal FM2.6 Discuss presumption (CAL)
patient. systems including of death and survivorship vectors of public
diuretics, antidiuretics- FM2.7 Describe and discuss health importance
vasopressin and analogues suspended animation Batch A
FM 2.8 Describe and
discuss postmortem changes
including signs of death,
cooling of body, post-
mortem lividity, rigor
mortis, cadaveric spasm,
cold stiffening and heat
stiffening
31/05/2022 Tuesday CM-SDL - 3.6 PH-L-1.24 MI-P PA-P SGD FM-P SGD - 7
Entomology:Role of vectors Describe the mechanism/s SDL-1 Forensic Pathology
rs in the causation of of action, types, doses, Lab Diagnosis of Diarrhoea 14.2 Describe the etiology, FM1.10 Select appropriate
disease,NVBDCPPeer side effects, indications & Dysentery investigations and cause of death in a particular
learning and contraindications of differential diagnosis of scenario by referring ICD 10
the drugs affecting renal microcytic hypochromic code
systems including anemia FM1.11Write a correct
diuretics, antidiuretics- 14.3 Identify and describe cause of death certificate as
vasopressin and analogues the peripheral smear in per ICD 10 document
microcytic anemia
BATCH A01/06/2022 Wednesday MED-L PA-L PH-SGD-1.24 PA-P SGD MI-P
Describe the mechanism/s 15.1 Describe the SGD
IM9.17 7.1 Define and classify of action, types, doses, side metabolism of Vitamin B12 3.2 Identify the common
Describe the indications for neoplasia. Describe the effects, indications and and the etiology and etiologic agents of diarrhea
blood transfusion and the characteristics of neoplasia contraindications of the pathogenesis of B12 and dysentery
appropriate use of blood including gross, microscopy, drugs affecting renal deficiency
components biologic, behaviour and systems including 15.2 Describe laboratory
spread. Differentiate diuretics, antidiuretics- investigations of macrocytic
between benign from vasopressin and analogues anemia
malignant neoplams
BATCH B
02/06/2022 Thursday OBG-L PA-L PH- 1.24 PA-P SGD MI-P
OG 1.1, 1,2 CM10.1, 10.2 SDL-2 15.1 Describe the SGD
Maternal and perinatal 7.2 Describe the molecular Describe the mechanism/s metabolism of Vitamin B12 3.2 Identify the common
mortality basis of cancer of action, types, doses, side and the etiology and etiologic agents of diarrhea
effects, indications and pathogenesis of B12 and dysentery
contraindications of the deficiency
drugs affecting renal 15.2 Describe laboratory
systems including investigations of macrocytic
diuretics, antidiuretics- anemia
vasopressin and analogues
BATCH A
03/06/2022 Friday MI-L PA-L PH-P-4.2 CM-
3.5 Enumerate the causative Demonstrate the effects of
agents of food poisoning 7.3 Enumerate carcinogens drugs on blood pressure P3.7Demonstration:I
and discuss the and describe the process of using computer aided dentifying
pathogenesis, clinical course carcinogenesis learning (Drugs on BP characteristics of
and laboratory diagnosis (CAL)
vectors of public
Lab diag of Food health importance
poisoning & Batch B
Gastroenteritis04/06/2022 Saturday MI-L PH-L-1.27 FM-P SGD - 8 PA-P SGD
3.7 Describe the Describe the mechanism s Forensic Pathology
10:00 AM-1:00 PM epidemiology, the etio- of action, types, doses, side FM 2.33 Demonstrate 15.3 Identify and describe
PH 3.1 Prescription pathogenesis and discuss the effects, indications and ability to use local resources the peripheral blood picture
communication viral markers in the contraindications of whenever required like in of macrocytic anemia
PH-P- 1.10 evolution of Viral hepatitis. antihypertensive drugs and mass disaster situations 15.4 Enumerate the
Describe parts of a correct, Discuss the modalities in the drugs used in shock FM 2.34 Demonstrate differences and describe the
Complete and legible diagnosis and prevention of ability to use local resources etiology and distinguishing
generic prescription. viral hepatitis whenever required like in features of megaloblastic
Identify errors in mass disaster situations and non-megaloblastic
prescription and correct Viral Hepatitis FM 2.35 Demonstrate macrocytic anemia
appropriately professionalism while BATCH B
conducting autopsy in
medicolegal situations,
interpretation of findings
and making inference/
opinion, collection
preservation and dispatch of
biological or trace evidences
Date Day 8-9 9-10 2-3 3-4 4-5
06/06/2022 Monday SUR-L PH-L -1.27 FM-Lecture -9 PH-P 1.10 CM-
SU12.1 Enumerate the IM-8.14 Forensic Pathology Describe parts of a correct,
causes and consequences of Describe the mechanism s FM2.9 Describe Complete and legible P3.7Demonstration:I
malnutrition in the of action, types, doses, putrefaction, generic dentifying
surgical patient side effects, indications mummification, adipocere prescription. Identify characteristics of
SU12.3 Discuss the and contraindications of and maceration errors in prescription
nutritional requirements of antihypertensive drugs and and correct vectors of public
surgical patients, themethods drugs used in shock appropriately health importance
of providing nutritional Batch A
support and their
complications07/06/2022 Tuesday CM SDL- 3.7,3.8 PH-L 1.28 MI-P PA-P SGD FM-P SGD - 8
Health Education – IM-2.15 Forensic Pathology
Prevention & Control of Describe the mechanisms 15.3 Identify and describe FM 2.33 Demonstrate
vector borne diseases Peer of action, types, doses, side SEMINAR the peripheral blood picture ability to use local resources
learning effects, indications and MRSA- Methicillin of macrocytic anemia whenever required like in
contraindications of the Resistant Staph Aureus 15.4 Enumerate the mass disaster situations
drugs used in ischemic differences and describe the FM 2.34 Demonstrate
heart disease (stable, etiology and distinguishing ability to use local resources
unstable angina and features of megaloblastic whenever required like in
myocardial infarction), and non-megaloblastic mass disaster situations
peripheral vascular disease macrocytic anemia FM 2.35 Demonstrate
BATCH A professionalism while
conducting autopsy in
medicolegal situations,
interpretation of findings
and making inference/
opinion, collection
preservation and dispatch of
biological or trace evidences
08/06/2022 Wednesday MED-L PA-L SDL PH- SGD-1.27 PA-P SGD MI-P-
10.1 Define and describe the Describe the mechanism s SGD
IM9.18 pathogenesis and pathology of action, types, doses, side 16.1 Define and classify 3.1,3.4
Describe the precautions of malaria effects, indications and hemolytic anemia Identify the different
required necessary when 10.2 Define and describe the contraindications of 16.2 Describe the modalities for diagnosis of
performing a blood pathogenesis and pathology antihypertensive drugs and pathogenesis and clinical enteric fever. Choose the
transfusion of cysticercosis drugs used in shock features and hematologic appropriate test related to
10.3 Define and describe the indices of hemolytic anemia the duration of illness
pathogenesis and pathology BATCH B
of leprosy
10.4 Define and describe the
pathogenesis and pathology
of common bacterial, viral,
protozoal and helminthic
diseases
09/06/2022 Thursday OBG-L PA-L PH-T-1.27 PA-P SGD MI-P-
OG- 5.1, 5.2 And 75.5 Describe the mechanism s SGD
Preconceptional counseling 7.4 Describe the effects of of action, types, doses, side 16.1 Define and classify 3.1,3.4
tumor on the host including effects, indications and hemolytic anemia Identify the different
paraneoplastic syndrome contraindications of 16.2 Describe the modalities for diagnosis of
antihypertensive drugs and pathogenesis and clinical enteric fever. Choose the
drugs used in shock features and hematologic appropriate test related to
indices of hemolytic anemia the duration of illness
BATCH A10/06/2022 Friday MI-L PA-L PH- P- 1.10 CM- P 8.1
7.1 Describe the etio- Describe parts of a correct,
pathogenesis and discuss the 7.5 Describe immunology Complete and legible Visit to public health
laboratory diagnosis of and the immune response to generic Microbiology
infections of genitourinary cancer prescription. Identify /Reference
system (STD) errors in prescription
and correct laboratories(RT-PCR
appropriately lab)
Batch B
11/06/2021 Saturday 10:00 AM-1:00 PM MI-L PH-L-1.29 FM-P SGD - 9 PA-P SGD
Pandemic Module 2.2 7.2 A Describe the etio- IM-1.24 Skills in Forensic Medicine
Microbiology pathogenesis and discuss the Describe the mechanism s & Toxicology 16.3 Describe the
laboratory diagnosis of of action, types, doses, side FM14.9 Demonstrate pathogenesis, features,
1. Small grp sexually transmitted effects, indications and examination of & present an hematologic indices and
discussion- 1hr infections. Recommend contraindications of the opinion after examination of peripheral blood picture of
2. Case finding & preventive measures- drugs used in congestive skeletal remains in a sickle cell anemia and
closure-2hrs Syphillis heart failure simulated/ supervised thalassemia
environment 16.4 Describe the etiology
pathogenesis, hematologic
indices and peripheral blood
picture of Acquired
hemolytic anemia
BATCH B
Date Day 8-9 9-10 2-3 3-4 4-5
13/06/2022 Monday SUR-L PH-L 1.29 FM-Lecture -10 PH-P- 1.10 CM- P 8.1
SU3.1 Describe the IM-1.24 Forensic Pathology Describe parts of a correct,
Indications and appropriate Describe the mechanism s FM2.10 Discuss estimation Complete and legible Visit to public health
use of blood and blood of action, types, doses, side of time since death generic Microbiology
products and complications effects, indications and prescription. Identify /Reference
of blood transfusion. contraindications of the errors in prescription
drugs used in congestive and correct laboratories(RT-PCR
heart failure appropriately lab)
Batch A14/06/2022 Tuesday CM-L -7.2 PH-L -1.30 MI-P PA-P SGD FM-P SGD - 9
Modes of transmission and Describe the mechanism s Skills in Forensic Medicine
measures for prevention & of action, types, doses, side SEMINAR 16.3 Describe the & Toxicology
control of communicable effects, indications and pathogenesis, features, FM14.9 Demonstrate
diseases-Part 1 contraindications of the Bioterrorism hematologic indices and examination of & present an
antiarrhythmics peripheral blood picture of opinion after examination of
sickle cell anemia and skeletal remains in a
Bioterrorism thalassemia simulated/ supervised
16.4 Describe the etiology environment
pathogenesis, hematologic
indices and peripheral blood
picture of Acquired
hemolytic anemia
BATCH A
15/06/2022 Wednesday MED-L PA-L PH-T-1.28 PA-P SGD MI-P-
IM15.12 Describe the mechanisms SGD
Enumerate the indications 11.1 Describe the of action, types, doses, side 16.5 Describe the peripheral 3.1 Enumerate the microbial
for whole blood, component pathogenesis and features of effects, indications and blood picture in different agents causing diarrhea and
and platelet common cytogenetic contraindications of the hemolytic anaemias dysentery. Describe the
transfusion and describe the abnormalities and mutations drugs used in ischemic 16.6 Prepare a peripheral epidemiology, morphology,
clinical features and in childhood heart disease (stable, blood smear and identify pathogenesis, clinical
management of a 11.2 Describe the unstable angina and hemolytic anaemia from it features and diagnostic
mismatched transfusion pathogenesis and pathology myocardial infarction), 16.7 Discribe the correct modalities of these agents-
of tumor and tumour- like peripheral vascular disease technique to perform a cross E.histolytica& Cestodes
conditions in infancy and match
childhood BATCH B
11.3 Describe the
pathogenesis of common
storage disorders in infancy
and childhood
16/06/2022 Thursday OBG-L PA-L SDL PH- SGD -1.28 PA-P SGD MI-P-
OG 8.1, 8.2(K), 8.3(K) Describe the mechanisms SGD
Antenatal Care, birth 11.1 Describe the of action, types, doses, side 16.5 Describe the peripheral 3.1 Enumerate the microbial
planning, and Obstetric pathogenesis and features of effects, indications and blood picture in different agents causing diarrhea and
examination common cytogenetic contraindications of the hemolytic anaemias dysentery. Describe the
abnormalities and mutations drugs used in ischemic 16.6 Prepare a peripheral epidemiology, morphology,
in childhood heart disease (stable, blood smear and identify pathogenesis, clinical
11.2 Describe the unstable angina and hemolytic anaemia from it features and diagnostic
pathogenesis and pathology myocardial infarction), 16.7 Discribe the correct modalities of these agents-
of tumor and tumour- like peripheral vascular disease technique to perform a cross E.histolytica&Cestodes
conditions in infancy and match
childhood BATCH A
11.3 Describe the
pathogenesis of common
storage disorders in infancy
and childhood17/06/2022 Friday MI-L PA-L PH-P- 1.10 CM-P8.4
7.2 B Describe the etio- 17.1 Enumerate the Describe parts of a correct,
pathogenesis and discuss etiology, pathogenesis and Complete and legible Preparation of
the laboratory diagnosis of findings in aplastic anemia generic epidemic curve/spot
sexually transmitted 17.2 Enumerate the prescription. Identify errors map with the help of
infections. Recommend indications and describe the in prescription
preventive measures- findings in bone marrow and correct given data and its
Gonorrhoea & aspiration and biopsy appropriately interpretation Batch
Herpesviruses B
18/06/2022 Saturday 10:00 AM-1:00 PM MI-L PH-L-1.35 FM-P SGD - 10 PA-P SGD
Pandemic Module 2.3 7.3 A Describe the etio- IM-9.15 Skills in Forensic Medicine
pathogenesis, clinical Describe the mechanism/s & Toxicology 6.1 Define and describe
Microbiology features, the appropriate of action, types, doses, FM14.4 Conduct and edema, its types,
method for specimen side effects, indications prepare report of estimation pathogenesis and clinical
1.Exploratory& interactive collection, and discuss the and contraindications of of age of a person for correlations
theory session- 1hr laboratory diagnosis of drugs used in medico-legal and other 6.2 Define and describe
2. Sample collection & Urinary tract infections hematological disorders purposes & prepare medico- hyperemia, congestion,
demo & hands on in skill like:1.Drugsused in legal report in a simulated/ hemorrhage
lab- 1hr anemias 2.CSF supervised environment
BATCH B
Discussion on HAND
WASHING TECHNIQUE
Date Day 8-9 9-10 2-3 3-4 4-5
20/06/2022 Monday SUR-L PH-L 1.35 FM-Lecture -11 PH-P-2.3 CM-P8.4
SU 9.1 Choose appropriate IM-9.15 Forensic Pathology Iv drip setting
biochemical, Describe the mechanism/s FM 2.19 Investigation of Preparation of
microbiological, of action, types, doses, anaesthetic, operative epidemic curve/spot
pathological,imaging side effects, indications deaths: Describe and map with the help of
investigations and interpret and contraindications of discuss special protocols for
the investigative data in conduction of autopsy and given data and its
drugs used in interpretation Batch
asurgical patient for collection, preservation
SU9.2 Biological basis for hematological disorders and dispatch of related
like:
A
early detection of cancer and material evidences
multidisciplinary 1. Drugs used in
21/06/2022 Tuesday approach in management of
CM-L PH-L
anemias1.25 MI-P PA-P SGD FM-P SGD - 10
cancer. IM-2.23
Colony Stimulating factors Skills in Forensic Medicine
7.2 Modes of transmission Describe 6.1 Define and describe & Toxicology
and measures for prevention the mechanism/s of SEMINAR edema, its types, FM14.4 Conduct and
& control of communicable action, types, doses, side MRSA- Methicillin pathogenesis and clinical prepare report of estimation
diseases-Part 2 effects, indications and Resistant Staph Aureus correlations of age of a person for
contraindications of the 6.2 Define and describe medico-legal and other
drugs acting on blood, hyperemia, congestion, purposes & prepare medico-
like anticoagulants, hemorrhage legal report in a simulated/
antiplatelets, supervised environment
BATCH A22/06/2022 Wednesday MED-L PA-L PH-1.29 PA-P SGD MI-P
IM13.1 SDL-3 3.8 Choose the appropriate
Describe the clinical 18.1 Enumerate and Describe the mechanism s 6.3 Define and describe laboratory test in the
epidemiology and inherited describe the causes of of action, types, doses, shock, its pathogenesis and diagnosis of viral hepatitis
& modifiable risk leucocytosis leucopenia side effects, indications its stages with emphasis on viral
factors for common lymphocytosis and and contraindications of 6.4 Define and describe markers
malignancies in India leukemoid reactions the drugs used in normal haemostasis and the
IM13.2 congestive heart failure etiopathogenesis and
Describe the genetic basis of consequences of thrombosis
selected cancers 6.5 Define and describe
embolism and its causes and
common types
BATCH B
23/06/2022 Thursday OBG-L PA-L PH-T 1.35 PA-P SGD MI-P
OG 8.4, 16.3 AN 75.5 IM-9.15 3.8 Choose the appropriate
Antenatal screening, genetic 18.2 Describe the etiology, Describe the mechanism/s 6.3 Define and describe laboratory test in the
counselling and antenatal genetics, pathogenesis , of action, types, doses, shock, its pathogenesis and diagnosis of viral hepatitis
monitoring of fetal well classification, features, side effects, indications its stages with emphasis on viral
being hematological features of and contraindications of 6.4 Define and describe markers
acute and chronic leukemia normal haemostasis and the
drugs used in
etiopathogenesis and
hematological disorders consequences of thrombosis
like: 6.5 Define and describe
2. Drugs used in embolism and its causes and
anemias common types
Colony Stimulating factors BATCH A
24/06/2022 Friday MI-L PA-L PH-P-2.3 CM-P19.2
7.3 B Describe the etio- Iv drip setting
pathogenesis, clinical 19.1 Enumerate the causes Visit to hospital
features, the appropriate and describe the pharmacy
method for specimen differentiating features of Batch B
collection, and discuss the lymphadenopathy
laboratory diagnosis of 19.2 Describe the
Urinary tract infections- pathogenesis and pathology
E.coli ,Klebsiella, Proteus of tuberculous
lymphadenitis
25/06/2022 Saturday 10:00 AM-1:00 PM MI-L PH-L- 1.25 FM-P SGD - 11 PA-P SGD
Pandemic Module 2.3 1.7A /PA 9.1 IM-2.23 Skills in Forensic Medicine
Describe the immunological Describe & Toxicology 6.6 Define and describe
Microbiology mechanisms in health the mechanism/s of FM14.21 To collect, Ischaemia/infarction its
action, types, doses, side preserve, seal and dispatch types, etiology, morphologic
3.Visit to Lab with demo of effects, indications and exhibits for DNAFinger changes and clinical effects
diagnostic test- Ihr contraindications of the printing using various 6.7 Identify and describe the
drugs acting on blood, formats of different gross and microscopic
4.Samll grp activity- like anticoagulants, laboratories features of infarction in a
antiplatelets, pathologic specimen
BATCH BDate Day 8-9 9-10 2-3 3-4 4-5
27/06/2022 Monday SUR-L PH-L PH-L-1.25 FM-L PH-P-2.3 CM-P19.2
SU 6.1Define and describe IM-2.23 Revision / Lapsed Topics Iv drip setting
the aetiology and Describe the mechanism Visit to hospital
pathogenesis of of action, types, doses, pharmacy
surgicalInfections side effects, indications and Batch A
SU6.2 Enumerate contraindications of drugs
Prophylactic and therapeutic acting on blood,
antibioticsPlan appropriate anticoagulants,
28/06/2022 Tuesday CM-L -8.1Epidemiological PH-L 1.31 IM-2.18 MI-P 8.6 PA-P SGD FM-P SGD - 11
management antiplatelets
& control measures Describe MOA, types, PS-4.6 Skills in Forensic Medicine
including the use of essential doses, side effects, Describe the basics of 6.6 Define and describe & Toxicology
laboratory tests at the indications of drugs used in Infection control Ischaemia/infarction its FM14.21 To collect,
primary care level for management of types, etiology, morphologic preserve, seal and dispatch
airborne infections : Measles dyslipidemia changes and clinical effects exhibits for DNAFinger
,Mumps & Rubella 6.7 Identify and describe the printing using various
gross and microscopic formats of different
features of infarction in a laboratories
pathologic specimen
BATCH A
29/06/2022 Wednesday MED-L PA-L PH-SGD- 1.25 PA-P SGD MI-P
IM13.5Describe the IM-2.23 7.1 Define and classify SGD
common issues encountered 19.4 Describe and discuss Describe neoplasia. Describe the 7.2
in patients at the end of the pathogenesis, pathology the mechanism/s of characteristics of neoplasia Describe the etio-
life and principles of and the differentiating action, types, doses, side including gross, microscopy, pathogenesis and discuss the
management features of Hodgkin's and effects, indications and biologic, behavior and laboratory diagnosis of
non-Hodgkin's lymphoma contraindications of the spread. Differentiate between sexually transmitted
IM13.6 Describe and drugs acting on blood, benign from malignant infections. Recommend
distinguish the difference AND like anticoagulants, neoplasms preventive measures-
between curative and antiplatelets, BATCH B Gonorrhoea & Syphilis
palliative care in patients 19.6 Enumerate and
with cancer differentiate the causes of
splenomegaly
30/06/2022 Thursday OBG-L PA-L PH-1.31 PA-P SGD MI-P
OG 8.7 SDL-4 7.1 Define and classify SGD
Vaccines and medications in 21.1 Describe normal Describe the mechanism neoplasia. Describe the 7.2
pregnancy, Teratology hemostasis of action, types, doses, characteristics of neoplasia Describe the etio-
side effects, indications and including gross, microscopy, pathogenesis and discuss the
contraindications of the biologic, behavior and laboratory diagnosis of
drugs used in the spread. Differentiate between sexually transmitted
management of benign from malignant infections. Recommend
dyslipidemias neoplasms preventive measures-
BATCH A Gonorrhoea& SyphilisYou can also read
